Dynamics of plasma proteome during leptin-replacement therapy in genetically based leptin deficiency

V. P. Andreev, R. C. Dwivedi, G. Paz-Filho, O. V. Krokhin, M. L. Wong, J. A. Wilkins, J. Licinio

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The effects of leptin-replacement therapy on the plasma proteome of three unique adults with genetically based leptin deficiency were studied longitudinally during the course of recombinant human leptin-replacement treatment. Quantitative proteomics analysis was performed in plasma samples collected during four stages: before leptin treatment was initiated, after 1.5 and 6 years of leptin-replacement treatment, and after 7 weeks of temporary interruption of leptin-replacement therapy. Of 500 proteins reliably identified and quantitated in those four stages, about 100 were differentially abundant twofold or more in one or more stages. Synchronous dynamics of abundances of about 90 proteins was observed reflecting both short- and long-term effects of leptin-replacement therapy. Pathways and processes enriched with overabundant synchronous proteins were cell adhesion, cytoskeleton remodeling, cell cycle, blood coagulation, glycolysis, and gluconeogenesis. Plausible common regulators of the above synchronous proteins were identified using transcription regulation network analysis. The generated network included two transcription factors (c-Myc and androgen receptor) that are known to activate each other through a double-positive feedback loop, which may represent a potential molecular mechanism for the long-term effects of leptin-replacement therapy. Our findings may help to elucidate the effects of leptin on insulin resistance.

Original languageEnglish
Pages (from-to)174-190
Number of pages17
JournalPharmacogenomics Journal
Volume11
Issue number3
DOIs
StatePublished - Jun 1 2011

Fingerprint

Proteome
Leptin
Therapeutics
Proteins
Gluconeogenesis
Androgen Receptors
Blood Coagulation
Glycolysis
Cytoskeleton
Cell Adhesion
Proteomics
Insulin Resistance
Cell Cycle
Transcription Factors

Keywords

  • enrichment analysis
  • insulin resistance
  • iTRAQ
  • leptin
  • obesity
  • plasma proteome

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine
  • Genetics

Cite this

Andreev, V. P., Dwivedi, R. C., Paz-Filho, G., Krokhin, O. V., Wong, M. L., Wilkins, J. A., & Licinio, J. (2011). Dynamics of plasma proteome during leptin-replacement therapy in genetically based leptin deficiency. Pharmacogenomics Journal, 11(3), 174-190. https://doi.org/10.1038/tpj.2010.30

Dynamics of plasma proteome during leptin-replacement therapy in genetically based leptin deficiency. / Andreev, V. P.; Dwivedi, R. C.; Paz-Filho, G.; Krokhin, O. V.; Wong, M. L.; Wilkins, J. A.; Licinio, J.

In: Pharmacogenomics Journal, Vol. 11, No. 3, 01.06.2011, p. 174-190.

Research output: Contribution to journalArticle

Andreev, VP, Dwivedi, RC, Paz-Filho, G, Krokhin, OV, Wong, ML, Wilkins, JA & Licinio, J 2011, 'Dynamics of plasma proteome during leptin-replacement therapy in genetically based leptin deficiency', Pharmacogenomics Journal, vol. 11, no. 3, pp. 174-190. https://doi.org/10.1038/tpj.2010.30
Andreev VP, Dwivedi RC, Paz-Filho G, Krokhin OV, Wong ML, Wilkins JA et al. Dynamics of plasma proteome during leptin-replacement therapy in genetically based leptin deficiency. Pharmacogenomics Journal. 2011 Jun 1;11(3):174-190. https://doi.org/10.1038/tpj.2010.30
Andreev, V. P. ; Dwivedi, R. C. ; Paz-Filho, G. ; Krokhin, O. V. ; Wong, M. L. ; Wilkins, J. A. ; Licinio, J. / Dynamics of plasma proteome during leptin-replacement therapy in genetically based leptin deficiency. In: Pharmacogenomics Journal. 2011 ; Vol. 11, No. 3. pp. 174-190.
@article{2cb5a8f6ac0544e7b6a4bc3b03eaf9b1,
title = "Dynamics of plasma proteome during leptin-replacement therapy in genetically based leptin deficiency",
abstract = "The effects of leptin-replacement therapy on the plasma proteome of three unique adults with genetically based leptin deficiency were studied longitudinally during the course of recombinant human leptin-replacement treatment. Quantitative proteomics analysis was performed in plasma samples collected during four stages: before leptin treatment was initiated, after 1.5 and 6 years of leptin-replacement treatment, and after 7 weeks of temporary interruption of leptin-replacement therapy. Of 500 proteins reliably identified and quantitated in those four stages, about 100 were differentially abundant twofold or more in one or more stages. Synchronous dynamics of abundances of about 90 proteins was observed reflecting both short- and long-term effects of leptin-replacement therapy. Pathways and processes enriched with overabundant synchronous proteins were cell adhesion, cytoskeleton remodeling, cell cycle, blood coagulation, glycolysis, and gluconeogenesis. Plausible common regulators of the above synchronous proteins were identified using transcription regulation network analysis. The generated network included two transcription factors (c-Myc and androgen receptor) that are known to activate each other through a double-positive feedback loop, which may represent a potential molecular mechanism for the long-term effects of leptin-replacement therapy. Our findings may help to elucidate the effects of leptin on insulin resistance.",
keywords = "enrichment analysis, insulin resistance, iTRAQ, leptin, obesity, plasma proteome",
author = "Andreev, {V. P.} and Dwivedi, {R. C.} and G. Paz-Filho and Krokhin, {O. V.} and Wong, {M. L.} and Wilkins, {J. A.} and J. Licinio",
year = "2011",
month = "6",
day = "1",
doi = "10.1038/tpj.2010.30",
language = "English",
volume = "11",
pages = "174--190",
journal = "Pharmacogenomics Journal",
issn = "1470-269X",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Dynamics of plasma proteome during leptin-replacement therapy in genetically based leptin deficiency

AU - Andreev, V. P.

AU - Dwivedi, R. C.

AU - Paz-Filho, G.

AU - Krokhin, O. V.

AU - Wong, M. L.

AU - Wilkins, J. A.

AU - Licinio, J.

PY - 2011/6/1

Y1 - 2011/6/1

N2 - The effects of leptin-replacement therapy on the plasma proteome of three unique adults with genetically based leptin deficiency were studied longitudinally during the course of recombinant human leptin-replacement treatment. Quantitative proteomics analysis was performed in plasma samples collected during four stages: before leptin treatment was initiated, after 1.5 and 6 years of leptin-replacement treatment, and after 7 weeks of temporary interruption of leptin-replacement therapy. Of 500 proteins reliably identified and quantitated in those four stages, about 100 were differentially abundant twofold or more in one or more stages. Synchronous dynamics of abundances of about 90 proteins was observed reflecting both short- and long-term effects of leptin-replacement therapy. Pathways and processes enriched with overabundant synchronous proteins were cell adhesion, cytoskeleton remodeling, cell cycle, blood coagulation, glycolysis, and gluconeogenesis. Plausible common regulators of the above synchronous proteins were identified using transcription regulation network analysis. The generated network included two transcription factors (c-Myc and androgen receptor) that are known to activate each other through a double-positive feedback loop, which may represent a potential molecular mechanism for the long-term effects of leptin-replacement therapy. Our findings may help to elucidate the effects of leptin on insulin resistance.

AB - The effects of leptin-replacement therapy on the plasma proteome of three unique adults with genetically based leptin deficiency were studied longitudinally during the course of recombinant human leptin-replacement treatment. Quantitative proteomics analysis was performed in plasma samples collected during four stages: before leptin treatment was initiated, after 1.5 and 6 years of leptin-replacement treatment, and after 7 weeks of temporary interruption of leptin-replacement therapy. Of 500 proteins reliably identified and quantitated in those four stages, about 100 were differentially abundant twofold or more in one or more stages. Synchronous dynamics of abundances of about 90 proteins was observed reflecting both short- and long-term effects of leptin-replacement therapy. Pathways and processes enriched with overabundant synchronous proteins were cell adhesion, cytoskeleton remodeling, cell cycle, blood coagulation, glycolysis, and gluconeogenesis. Plausible common regulators of the above synchronous proteins were identified using transcription regulation network analysis. The generated network included two transcription factors (c-Myc and androgen receptor) that are known to activate each other through a double-positive feedback loop, which may represent a potential molecular mechanism for the long-term effects of leptin-replacement therapy. Our findings may help to elucidate the effects of leptin on insulin resistance.

KW - enrichment analysis

KW - insulin resistance

KW - iTRAQ

KW - leptin

KW - obesity

KW - plasma proteome

UR - http://www.scopus.com/inward/record.url?scp=79957509734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957509734&partnerID=8YFLogxK

U2 - 10.1038/tpj.2010.30

DO - 10.1038/tpj.2010.30

M3 - Article

VL - 11

SP - 174

EP - 190

JO - Pharmacogenomics Journal

JF - Pharmacogenomics Journal

SN - 1470-269X

IS - 3

ER -